← Browse by Condition
Medical Condition
relapsed refractory multiple myeloma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, EARLY_Phase 1
NCT06049290 Phase 1, Phase 2
Recruiting
A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Enrollment
342 pts
Location
China
Sponsor
Nanjing Leads Biolabs Co.,Ltd
NCT06718270 EARLY_Phase 1
Recruiting
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
Enrollment
24 pts
Location
China
Sponsor
Shanghai Changzheng Hospital
NCT05160584
Recruiting
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
Enrollment
300 pts
Location
Austria, Belgium, Fr...
Sponsor
Janssen Pharmaceutica N.V., Be...